Marginal Kidneys Benefit Older Recipients
SAN FRANCISCO—The use of marginal donor kidneys is associated with similar five-year death-censored graft survival and patient survival as ideal donor kidneys in older recipients, a study shows.
Diagnosis & Disease Information
For Semen Collection, Privacy Please
WASHINGTON, D.C.—A recent survey identified what men would like in a semen collection room at an assisted reproduction clinic. They want sound privacy, cleanliness, and face-to-face instruction.
High BK Virus Infection Rate Found
CHICAGO—Spanish researchers say they have found a high rate of BK virus (BKV) viremia during the first six months after renal transplantation, but after that the rate declines significantly.
Hydration May Cut Calcium Stone Risk
SAN FRANCISCO—By drinking more water, especially during the night, calcium stone formers may reduce their stone risk, according to a study presented here at Renal Week 2007.
Should Selling of Kidneys Be Allowed?
The ability to purchase organs from live donors could largely eliminate transplant waiting times and only modestly increase total transplantation costs, according to a newly published economic analysis.
ED Is a Predictor of Cardiac Disease: A Urologic Perspective
Erectile dysfuction (ED), defined as the inability to reach or maintain an erection sufficient for satisfactory sexual performance, is age-related and an extremely prevalent medical condition. It is estimated to affect more than half of all men over the age of 60, and in the United States alone, ED will develop in more than 600,000 men aged 40-69 annually.1
Manufacturing Issue Delays Restart of CIS Drug
Indevus Pharmaceuticals, Inc., of Lexington, Mass., has received a non-approvable letter from the FDA for Valstar (valrubicin solution), the only approved product for therapy of bacillus Calmette-Guérin-refractory carcinoma in situ of the urinary bladder.
ARB Cleared to Treat High BP in Children
Diovan (valsartan), an angiotensin receptor blocker (ARB) marketed by Novartis Pharmaceuticals of East Hanover, N.J., has been approved for treating hypertension in children and adolescents aged six to 16.
New Dosage for Glycemic Control in Type 2 Diabetes
Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination with a sulfonylurea or insulin as an adjunctive therapy to improve glycemic control in adult type 2 diabetes patients.
Once-Daily Use of Tadalafil for ED Okayed
The FDA has approved Cialis (tadalafil) for once-daily use (2.5 mg and 5 mg) to treat erectile dysfunction (ED).
- Loading...
Loading...
Loading... 
Loading...